The glucagon-like peptide-1 (GLP-1) receptor agonists are well-known for causing stomach side effects, but these are typically tolerable and short-term for most people
Common adverse effects observed in clinical trials include nausea, vomiting, injection site reactions, increased heart rate, and hypoglycaemia risk
Consequently, our systematic review and meta-analysis lends support to the hypothesized potential of gastrointestinal hormones to modulate reward responses in humans
The lack of upregulation of SLC22A5 at the gene level in CAR suggests that existing transporter capacities in bovine PBMC were adequate to handle the higher substrate flux from the extracellular to the intracellular space
The placebo group's average weight loss was only 0.3%
It supports the conversation by giving patients a structured handbook they can read, revisit and apply between appointments